1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Therapeutic Nuclear Medicines Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Therapeutic Nuclear Medicines by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Therapeutic Nuclear Medicines by Country/Region, 2017, 2022 & 2028

2.2 Therapeutic Nuclear Medicines Segment by Type

2.2.1 Radium-223

2.2.2 Lutetium-177

2.2.3 Iodine-131

2.2.4 Other

2.3 Therapeutic Nuclear Medicines Sales by Type

2.3.1 Global Therapeutic Nuclear Medicines Sales Market Share by Type (2017-2022)

2.3.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Type (2017-2022)

2.3.3 Global Therapeutic Nuclear Medicines Sale Price by Type (2017-2022)

2.4 Therapeutic Nuclear Medicines Segment by Application

2.4.1 Thyroid

2.4.2 Bone Metastasis

2.4.3 Lymphoma

2.4.4 Other

2.5 Therapeutic Nuclear Medicines Sales by Application

2.5.1 Global Therapeutic Nuclear Medicines Sale Market Share by Application (2017-2022)

2.5.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Application (2017-2022)

2.5.3 Global Therapeutic Nuclear Medicines Sale Price by Application (2017-2022)

3 Global Therapeutic Nuclear Medicines by Company

3.1 Global Therapeutic Nuclear Medicines Breakdown Data by Company

3.1.1 Global Therapeutic Nuclear Medicines Annual Sales by Company (2020-2022)

3.1.2 Global Therapeutic Nuclear Medicines Sales Market Share by Company (2020-2022)

3.2 Global Therapeutic Nuclear Medicines Annual Revenue by Company (2020-2022)

3.2.1 Global Therapeutic Nuclear Medicines Revenue by Company (2020-2022)

3.2.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Company (2020-2022)

3.3 Global Therapeutic Nuclear Medicines Sale Price by Company

3.4 Key Manufacturers Therapeutic Nuclear Medicines Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Therapeutic Nuclear Medicines Product Location Distribution

3.4.2 Players Therapeutic Nuclear Medicines Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Therapeutic Nuclear Medicines by Geographic Region

4.1 World Historic Therapeutic Nuclear Medicines Market Size by Geographic Region (2017-2022)

4.1.1 Global Therapeutic Nuclear Medicines Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Therapeutic Nuclear Medicines Annual Revenue by Geographic Region

4.2 World Historic Therapeutic Nuclear Medicines Market Size by Country/Region (2017-2022)

4.2.1 Global Therapeutic Nuclear Medicines Annual Sales by Country/Region (2017-2022)

4.2.2 Global Therapeutic Nuclear Medicines Annual Revenue by Country/Region

4.3 Americas Therapeutic Nuclear Medicines Sales Growth

4.4 APAC Therapeutic Nuclear Medicines Sales Growth

4.5 Europe Therapeutic Nuclear Medicines Sales Growth

4.6 Middle East & Africa Therapeutic Nuclear Medicines Sales Growth

5 Americas

5.1 Americas Therapeutic Nuclear Medicines Sales by Country

5.1.1 Americas Therapeutic Nuclear Medicines Sales by Country (2017-2022)

5.1.2 Americas Therapeutic Nuclear Medicines Revenue by Country (2017-2022)

5.2 Americas Therapeutic Nuclear Medicines Sales by Type

5.3 Americas Therapeutic Nuclear Medicines Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Therapeutic Nuclear Medicines Sales by Region

6.1.1 APAC Therapeutic Nuclear Medicines Sales by Region (2017-2022)

6.1.2 APAC Therapeutic Nuclear Medicines Revenue by Region (2017-2022)

6.2 APAC Therapeutic Nuclear Medicines Sales by Type

6.3 APAC Therapeutic Nuclear Medicines Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Therapeutic Nuclear Medicines by Country

7.1.1 Europe Therapeutic Nuclear Medicines Sales by Country (2017-2022)

7.1.2 Europe Therapeutic Nuclear Medicines Revenue by Country (2017-2022)

7.2 Europe Therapeutic Nuclear Medicines Sales by Type

7.3 Europe Therapeutic Nuclear Medicines Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Therapeutic Nuclear Medicines by Country

8.1.1 Middle East & Africa Therapeutic Nuclear Medicines Sales by Country (2017-2022)

8.1.2 Middle East & Africa Therapeutic Nuclear Medicines Revenue by Country (2017-2022)

8.2 Middle East & Africa Therapeutic Nuclear Medicines Sales by Type

8.3 Middle East & Africa Therapeutic Nuclear Medicines Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Therapeutic Nuclear Medicines

10.3 Manufacturing Process Analysis of Therapeutic Nuclear Medicines

10.4 Industry Chain Structure of Therapeutic Nuclear Medicines

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Therapeutic Nuclear Medicines Distributors

11.3 Therapeutic Nuclear Medicines Customer

12 World Forecast Review for Therapeutic Nuclear Medicines by Geographic Region

12.1 Global Therapeutic Nuclear Medicines Market Size Forecast by Region

12.1.1 Global Therapeutic Nuclear Medicines Forecast by Region (2023-2028)

12.1.2 Global Therapeutic Nuclear Medicines Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Therapeutic Nuclear Medicines Forecast by Type

12.7 Global Therapeutic Nuclear Medicines Forecast by Application

13 Key Players Analysis

13.1 Novartis AG

13.1.1 Novartis AG Company Information

13.1.2 Novartis AG Therapeutic Nuclear Medicines Product Offered

13.1.3 Novartis AG Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Novartis AG Main Business Overview

13.1.5 Novartis AG Latest Developments

13.2 Bayer

13.2.1 Bayer Company Information

13.2.2 Bayer Therapeutic Nuclear Medicines Product Offered

13.2.3 Bayer Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Bayer Main Business Overview

13.2.5 Bayer Latest Developments

13.3 China Isotope & Radiation

13.3.1 China Isotope & Radiation Company Information

13.3.2 China Isotope & Radiation Therapeutic Nuclear Medicines Product Offered

13.3.3 China Isotope & Radiation Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 China Isotope & Radiation Main Business Overview

13.3.5 China Isotope & Radiation Latest Developments

13.4 Q BioMed

13.4.1 Q BioMed Company Information

13.4.2 Q BioMed Therapeutic Nuclear Medicines Product Offered

13.4.3 Q BioMed Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Q BioMed Main Business Overview

13.4.5 Q BioMed Latest Developments

13.5 Curium Pharmaceuticals

13.5.1 Curium Pharmaceuticals Company Information

13.5.2 Curium Pharmaceuticals Therapeutic Nuclear Medicines Product Offered

13.5.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Curium Pharmaceuticals Main Business Overview

13.5.5 Curium Pharmaceuticals Latest Developments

13.6 Jubilant DraxImage

13.6.1 Jubilant DraxImage Company Information

13.6.2 Jubilant DraxImage Therapeutic Nuclear Medicines Product Offered

13.6.3 Jubilant DraxImage Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Jubilant DraxImage Main Business Overview

13.6.5 Jubilant DraxImage Latest Developments

13.7 Dongcheng

13.7.1 Dongcheng Company Information

13.7.2 Dongcheng Therapeutic Nuclear Medicines Product Offered

13.7.3 Dongcheng Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Dongcheng Main Business Overview

13.7.5 Dongcheng Latest Developments

13.8 Lantheus

13.8.1 Lantheus Company Information

13.8.2 Lantheus Therapeutic Nuclear Medicines Product Offered

13.8.3 Lantheus Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Lantheus Main Business Overview

13.8.5 Lantheus Latest Developments

13.9 Acrotech Biopharma.

13.9.1 Acrotech Biopharma. Company Information

13.9.2 Acrotech Biopharma. Therapeutic Nuclear Medicines Product Offered

13.9.3 Acrotech Biopharma. Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Acrotech Biopharma. Main Business Overview

13.9.5 Acrotech Biopharma. Latest Developments

13.10 Progenics Pharmaceuticals

13.10.1 Progenics Pharmaceuticals Company Information

13.10.2 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product Offered

13.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Progenics Pharmaceuticals Main Business Overview

13.10.5 Progenics Pharmaceuticals Latest Developments

13.11 International Isotopes

13.11.1 International Isotopes Company Information

13.11.2 International Isotopes Therapeutic Nuclear Medicines Product Offered

13.11.3 International Isotopes Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 International Isotopes Main Business Overview

13.11.5 International Isotopes Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Therapeutic Nuclear Medicines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Therapeutic Nuclear Medicines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Radium-223

Table 4. Major Players of Lutetium-177

Table 5. Major Players of Iodine-131

Table 6. Major Players of Other

Table 7. Global Therapeutic Nuclear Medicines Sales by Type (2017-2022) & (K Units)

Table 8. Global Therapeutic Nuclear Medicines Sales Market Share by Type (2017-2022)

Table 9. Global Therapeutic Nuclear Medicines Revenue by Type (2017-2022) & ($ million)

Table 10. Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2017-2022)

Table 11. Global Therapeutic Nuclear Medicines Sale Price by Type (2017-2022) & (USD/Unit)

Table 12. Global Therapeutic Nuclear Medicines Sales by Application (2017-2022) & (K Units)

Table 13. Global Therapeutic Nuclear Medicines Sales Market Share by Application (2017-2022)

Table 14. Global Therapeutic Nuclear Medicines Revenue by Application (2017-2022)

Table 15. Global Therapeutic Nuclear Medicines Revenue Market Share by Application (2017-2022)

Table 16. Global Therapeutic Nuclear Medicines Sale Price by Application (2017-2022) & (USD/Unit)

Table 17. Global Therapeutic Nuclear Medicines Sales by Company (2020-2022) & (K Units)

Table 18. Global Therapeutic Nuclear Medicines Sales Market Share by Company (2020-2022)

Table 19. Global Therapeutic Nuclear Medicines Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Therapeutic Nuclear Medicines Revenue Market Share by Company (2020-2022)

Table 21. Global Therapeutic Nuclear Medicines Sale Price by Company (2020-2022) & (USD/Unit)

Table 22. Key Manufacturers Therapeutic Nuclear Medicines Producing Area Distribution and Sales Area

Table 23. Players Therapeutic Nuclear Medicines Products Offered

Table 24. Therapeutic Nuclear Medicines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Therapeutic Nuclear Medicines Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global Therapeutic Nuclear Medicines Sales Market Share Geographic Region (2017-2022)

Table 29. Global Therapeutic Nuclear Medicines Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Therapeutic Nuclear Medicines Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Therapeutic Nuclear Medicines Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global Therapeutic Nuclear Medicines Sales Market Share by Country/Region (2017-2022)

Table 33. Global Therapeutic Nuclear Medicines Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Therapeutic Nuclear Medicines Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Therapeutic Nuclear Medicines Sales by Country (2017-2022) & (K Units)

Table 36. Americas Therapeutic Nuclear Medicines Sales Market Share by Country (2017-2022)

Table 37. Americas Therapeutic Nuclear Medicines Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Therapeutic Nuclear Medicines Revenue Market Share by Country (2017-2022)

Table 39. Americas Therapeutic Nuclear Medicines Sales by Type (2017-2022) & (K Units)

Table 40. Americas Therapeutic Nuclear Medicines Sales Market Share by Type (2017-2022)

Table 41. Americas Therapeutic Nuclear Medicines Sales by Application (2017-2022) & (K Units)

Table 42. Americas Therapeutic Nuclear Medicines Sales Market Share by Application (2017-2022)

Table 43. APAC Therapeutic Nuclear Medicines Sales by Region (2017-2022) & (K Units)

Table 44. APAC Therapeutic Nuclear Medicines Sales Market Share by Region (2017-2022)

Table 45. APAC Therapeutic Nuclear Medicines Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Therapeutic Nuclear Medicines Revenue Market Share by Region (2017-2022)

Table 47. APAC Therapeutic Nuclear Medicines Sales by Type (2017-2022) & (K Units)

Table 48. APAC Therapeutic Nuclear Medicines Sales Market Share by Type (2017-2022)

Table 49. APAC Therapeutic Nuclear Medicines Sales by Application (2017-2022) & (K Units)

Table 50. APAC Therapeutic Nuclear Medicines Sales Market Share by Application (2017-2022)

Table 51. Europe Therapeutic Nuclear Medicines Sales by Country (2017-2022) & (K Units)

Table 52. Europe Therapeutic Nuclear Medicines Sales Market Share by Country (2017-2022)

Table 53. Europe Therapeutic Nuclear Medicines Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Therapeutic Nuclear Medicines Revenue Market Share by Country (2017-2022)

Table 55. Europe Therapeutic Nuclear Medicines Sales by Type (2017-2022) & (K Units)

Table 56. Europe Therapeutic Nuclear Medicines Sales Market Share by Type (2017-2022)

Table 57. Europe Therapeutic Nuclear Medicines Sales by Application (2017-2022) & (K Units)

Table 58. Europe Therapeutic Nuclear Medicines Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Therapeutic Nuclear Medicines Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa Therapeutic Nuclear Medicines Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Therapeutic Nuclear Medicines Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Therapeutic Nuclear Medicines Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Therapeutic Nuclear Medicines Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa Therapeutic Nuclear Medicines Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Therapeutic Nuclear Medicines Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa Therapeutic Nuclear Medicines Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Therapeutic Nuclear Medicines

Table 68. Key Market Challenges & Risks of Therapeutic Nuclear Medicines

Table 69. Key Industry Trends of Therapeutic Nuclear Medicines

Table 70. Therapeutic Nuclear Medicines Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Therapeutic Nuclear Medicines Distributors List

Table 73. Therapeutic Nuclear Medicines Customer List

Table 74. Global Therapeutic Nuclear Medicines Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global Therapeutic Nuclear Medicines Sales Market Forecast by Region

Table 76. Global Therapeutic Nuclear Medicines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Therapeutic Nuclear Medicines Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Therapeutic Nuclear Medicines Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas Therapeutic Nuclear Medicines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Therapeutic Nuclear Medicines Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC Therapeutic Nuclear Medicines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Therapeutic Nuclear Medicines Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe Therapeutic Nuclear Medicines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Therapeutic Nuclear Medicines Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa Therapeutic Nuclear Medicines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Therapeutic Nuclear Medicines Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global Therapeutic Nuclear Medicines Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Therapeutic Nuclear Medicines Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Therapeutic Nuclear Medicines Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Therapeutic Nuclear Medicines Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global Therapeutic Nuclear Medicines Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Therapeutic Nuclear Medicines Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Therapeutic Nuclear Medicines Revenue Market Share Forecast by Application (2023-2028)

Table 94. Novartis AG Basic Information, Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 95. Novartis AG Therapeutic Nuclear Medicines Product Offered

Table 96. Novartis AG Therapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 97. Novartis AG Main Business

Table 98. Novartis AG Latest Developments

Table 99. Bayer Basic Information, Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 100. Bayer Therapeutic Nuclear Medicines Product Offered

Table 101. Bayer Therapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 102. Bayer Main Business

Table 103. Bayer Latest Developments

Table 104. China Isotope & Radiation Basic Information, Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 105. China Isotope & Radiation Therapeutic Nuclear Medicines Product Offered

Table 106. China Isotope & Radiation Therapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 107. China Isotope & Radiation Main Business

Table 108. China Isotope & Radiation Latest Developments

Table 109. Q BioMed Basic Information, Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 110. Q BioMed Therapeutic Nuclear Medicines Product Offered

Table 111. Q BioMed Therapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 112. Q BioMed Main Business

Table 113. Q BioMed Latest Developments

Table 114. Curium Pharmaceuticals Basic Information, Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 115. Curium Pharmaceuticals Therapeutic Nuclear Medicines Product Offered

Table 116. Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 117. Curium Pharmaceuticals Main Business

Table 118. Curium Pharmaceuticals Latest Developments

Table 119. Jubilant DraxImage Basic Information, Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 120. Jubilant DraxImage Therapeutic Nuclear Medicines Product Offered

Table 121. Jubilant DraxImage Therapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 122. Jubilant DraxImage Main Business

Table 123. Jubilant DraxImage Latest Developments

Table 124. Dongcheng Basic Information, Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 125. Dongcheng Therapeutic Nuclear Medicines Product Offered

Table 126. Dongcheng Therapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 127. Dongcheng Main Business

Table 128. Dongcheng Latest Developments

Table 129. Lantheus Basic Information, Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 130. Lantheus Therapeutic Nuclear Medicines Product Offered

Table 131. Lantheus Therapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 132. Lantheus Main Business

Table 133. Lantheus Latest Developments

Table 134. Acrotech Biopharma. Basic Information, Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 135. Acrotech Biopharma. Therapeutic Nuclear Medicines Product Offered

Table 136. Acrotech Biopharma. Therapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 137. Acrotech Biopharma. Main Business

Table 138. Acrotech Biopharma. Latest Developments

Table 139. Progenics Pharmaceuticals Basic Information, Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 140. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product Offered

Table 141. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 142. Progenics Pharmaceuticals Main Business

Table 143. Progenics Pharmaceuticals Latest Developments

Table 144. International Isotopes Basic Information, Therapeutic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 145. International Isotopes Therapeutic Nuclear Medicines Product Offered

Table 146. International Isotopes Therapeutic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 147. International Isotopes Main Business

Table 148. International Isotopes Latest Developments

List of Figures

Figure 1. Picture of Therapeutic Nuclear Medicines

Figure 2. Therapeutic Nuclear Medicines Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Therapeutic Nuclear Medicines Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Therapeutic Nuclear Medicines Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Therapeutic Nuclear Medicines Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Radium-223

Figure 10. Product Picture of Lutetium-177

Figure 11. Product Picture of Iodine-131

Figure 12. Product Picture of Other

Figure 13. Global Therapeutic Nuclear Medicines Sales Market Share by Type in 2021

Figure 14. Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2017-2022)

Figure 15. Therapeutic Nuclear Medicines Consumed in Thyroid

Figure 16. Global Therapeutic Nuclear Medicines Market: Thyroid (2017-2022) & (K Units)

Figure 17. Therapeutic Nuclear Medicines Consumed in Bone Metastasis

Figure 18. Global Therapeutic Nuclear Medicines Market: Bone Metastasis (2017-2022) & (K Units)

Figure 19. Therapeutic Nuclear Medicines Consumed in Lymphoma

Figure 20. Global Therapeutic Nuclear Medicines Market: Lymphoma (2017-2022) & (K Units)

Figure 21. Therapeutic Nuclear Medicines Consumed in Other

Figure 22. Global Therapeutic Nuclear Medicines Market: Other (2017-2022) & (K Units)

Figure 23. Global Therapeutic Nuclear Medicines Sales Market Share by Application (2017-2022)

Figure 24. Global Therapeutic Nuclear Medicines Revenue Market Share by Application in 2021

Figure 25. Therapeutic Nuclear Medicines Revenue Market by Company in 2021 ($ Million)

Figure 26. Global Therapeutic Nuclear Medicines Revenue Market Share by Company in 2021

Figure 27. Global Therapeutic Nuclear Medicines Sales Market Share by Geographic Region (2017-2022)

Figure 28. Global Therapeutic Nuclear Medicines Revenue Market Share by Geographic Region in 2021

Figure 29. Global Therapeutic Nuclear Medicines Sales Market Share by Region (2017-2022)

Figure 30. Global Therapeutic Nuclear Medicines Revenue Market Share by Country/Region in 2021

Figure 31. Americas Therapeutic Nuclear Medicines Sales 2017-2022 (K Units)

Figure 32. Americas Therapeutic Nuclear Medicines Revenue 2017-2022 ($ Millions)

Figure 33. APAC Therapeutic Nuclear Medicines Sales 2017-2022 (K Units)

Figure 34. APAC Therapeutic Nuclear Medicines Revenue 2017-2022 ($ Millions)

Figure 35. Europe Therapeutic Nuclear Medicines Sales 2017-2022 (K Units)

Figure 36. Europe Therapeutic Nuclear Medicines Revenue 2017-2022 ($ Millions)

Figure 37. Middle East & Africa Therapeutic Nuclear Medicines Sales 2017-2022 (K Units)

Figure 38. Middle East & Africa Therapeutic Nuclear Medicines Revenue 2017-2022 ($ Millions)

Figure 39. Americas Therapeutic Nuclear Medicines Sales Market Share by Country in 2021

Figure 40. Americas Therapeutic Nuclear Medicines Revenue Market Share by Country in 2021

Figure 41. United States Therapeutic Nuclear Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 42. Canada Therapeutic Nuclear Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 43. Mexico Therapeutic Nuclear Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 44. Brazil Therapeutic Nuclear Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 45. APAC Therapeutic Nuclear Medicines Sales Market Share by Region in 2021

Figure 46. APAC Therapeutic Nuclear Medicines Revenue Market Share by Regions in 2021

Figure 47. China Therapeutic Nuclear Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 48. Japan Therapeutic Nuclear Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 49. South Korea Therapeutic Nuclear Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 50. Southeast Asia Therapeutic Nuclear Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 51. India Therapeutic Nuclear Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 52. Australia Therapeutic Nuclear Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 53. Europe Therapeutic Nuclear Medicines Sales Market Share by Country in 2021

Figure 54. Europe Therapeutic Nuclear Medicines Revenue Market Share by Country in 2021

Figure 55. Germany Therapeutic Nuclear Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 56. France Therapeutic Nuclear Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 57. UK Therapeutic Nuclear Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 58. Italy Therapeutic Nuclear Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 59. Russia Therapeutic Nuclear Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 60. Middle East & Africa Therapeutic Nuclear Medicines Sales Market Share by Country in 2021

Figure 61. Middle East & Africa Therapeutic Nuclear Medicines Revenue Market Share by Country in 2021

Figure 62. Egypt Therapeutic Nuclear Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 63. South Africa Therapeutic Nuclear Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 64. Israel Therapeutic Nuclear Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 65. Turkey Therapeutic Nuclear Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 66. GCC Country Therapeutic Nuclear Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 67. Manufacturing Cost Structure Analysis of Therapeutic Nuclear Medicines in 2021

Figure 68. Manufacturing Process Analysis of Therapeutic Nuclear Medicines

Figure 69. Industry Chain Structure of Therapeutic Nuclear Medicines

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles